Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Acq. announced Appointed director CC transcript Asset disposition Inv. presentation Director departure
|
HOLOGIC INC (HOLX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/06/2020 |
8-K
| Asset disposition
Docs:
|
"Hologic Completes Divestiture of Cynosure Medical Aesthetics Business",
"Hologic, Inc. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION On December 30, 2019, Hologic, Inc. completed the sale of its Medical Aesthetics business to an affiliate of investment funds managed by Clayton, Dubilier & Rice, LLC . The Medical Aesthetics business offers a portfolio of aesthetic treatment systems, including SculpSure, PicoSure, MonaLisa Touch and TempSure that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands, improve gynecologic health and use a radio frequency..." |
|
02/02/2017 |
8-K
| Form 8-K - Current report |
|
|